Psychedelic Therapy’s Odyssey and the Role of Spirituality

December 14, 2023

Veterans Subcommittee Hearing Highlights Potential of MDMA, Psilocybin Therapy 

November 19, 2023

NRx Pharmaceuticals Plans to Spin Off Ketamine-Focused Company

November 16, 2023

ATMA Announces Collaboration with Aviva Fohrer to Develop KAT Protocols for Addiction Treatment

November 8, 2023

Cybin Psilocybin Phase 2 Trial Shows Significant Reduction in Depressive Symptoms

November 3, 2023